Insider Selling: Cytokinetics, Incorporated (NASDAQ:CYTK) CEO Sells $471,000.00 in Stock

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Rating) CEO Robert I. Blum sold 12,500 shares of the business’s stock in a transaction that occurred on Friday, April 28th. The shares were sold at an average price of $37.68, for a total value of $471,000.00. Following the completion of the sale, the chief executive officer now owns 441,058 […]

Related Keywords

United States ,New York ,China ,Arizona ,America ,Roberti Blum , ,Needham Company ,Cantor Fitzgerald ,China Universal Asset Management Co ,Cytokinetics Inc ,Cytokinetics Incorporated ,Securities Exchange Commission ,Sg Americas Securities ,Get Rating ,Exchange Commission ,Universal Asset Management ,York State Teachers Retirement System ,State Retirement System ,Employees Deferred Compensation Plan ,Cytokinetics Daily ,Cytokinetics ,Nasdaq Cytk ,Cytk ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,